Eli Lilly’s experimental weight-loss pill, orforglipron, achieved nearly 8% weight loss and notable blood sugar reduction in a late-stage trial for patients with type 2 diabetes. The once-daily oral drug exceeded Wall Street expectations, triggering
.jpg)
In an exclusive interaction with India Pharma Outlook, Chandra Ganjoo, Group CEO of Trivitron Healthcare, discusses how MedTech in India is advancing healthcare through AI-driven diagnostics, local manufacturing, and policy support...
The Authentication Solution Providers’ Association (ASPA) will organize an Open House event on April 24, 2025, at Anantara Downtown Dubai, starting 5:00 PM onwards aimed at protecting consumers, businesses, and economies from the growing threat of
With the increasing scrutiny on drug safety and efficacy, understanding impurities is more important than ever and ever evolving guidelines are not aiding the efforts. To address those lacunas, Eminence has come up with 3rd Annual Pharma Impurity Con
A promising therapeutic option has been proposed at the Jawaharlal Nehru Centre for Advanced Scientific Research for treating...
Researchers believe that they have unearthed a fresh genetic cause of neurodevelopmental disorders that have never before...
Novartis is launching its latest investment initiative shortly after President Donald Trump introduced sweeping new tariffs on...
.jpg)
Speaking at the IMC Bharat Calling conference, Meenakshi Nevatia, Country President & Managing Director, Pfizer India, shared her views on how India is a key player in pharma innovation through advanced manufacturing, clinical trials...
Novo Nordisk has made the complete SOUL results presentation today, the results from a 3-phase cardiovascular outcomes study indicated that oral semaglutide significantly decreased the risk of major adverse cardiovascular events in adults with...
The anti-obesity drug market in India experienced a remarkable fourfold increase from March 2021 to March 2025 according to PharmaTrac data with a value growth from ?133 crore to ?576 crore. The market points to lifestyle disorders as well as consume
, CDSCO.jpg)
